United States of America and The State of North Carolina, ex rel. Santhosh Reddy Devarapally, M.D. v. Ferncreek Cardiology, P.A.; Matthew A. Daka, M.D.; Selvaratnam Sinna, M.D.; and Manesh Thomas, M.D.

CourtDistrict Court, E.D. North Carolina
DecidedDecember 12, 2025
Docket5:17-cv-00616
StatusUnknown

This text of United States of America and The State of North Carolina, ex rel. Santhosh Reddy Devarapally, M.D. v. Ferncreek Cardiology, P.A.; Matthew A. Daka, M.D.; Selvaratnam Sinna, M.D.; and Manesh Thomas, M.D. (United States of America and The State of North Carolina, ex rel. Santhosh Reddy Devarapally, M.D. v. Ferncreek Cardiology, P.A.; Matthew A. Daka, M.D.; Selvaratnam Sinna, M.D.; and Manesh Thomas, M.D.) is published on Counsel Stack Legal Research, covering District Court, E.D. North Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States of America and The State of North Carolina, ex rel. Santhosh Reddy Devarapally, M.D. v. Ferncreek Cardiology, P.A.; Matthew A. Daka, M.D.; Selvaratnam Sinna, M.D.; and Manesh Thomas, M.D., (E.D.N.C. 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NORTH CAROLINA WESTERN DIVISION

NO. 5:17-CV-616-FL

UNITED STATES OF AMERICA and ) THE STATE OF NORTH CAROLINA, ex ) rel. SANTHOSH REDDY ) DEVARAPALLY, M.D., ) ) Plaintiffs, ) ) v. ) MEMORANDUM OPINION ) FERNCREEK CARDIOLOGY, P.A.; ) MATTHEW A. DAKA, M.D.; ) SELVARATNAM SINNA, M.D.; and ) MANESH THOMAS, M.D., ) ) Defendants. )

At trial November 20, 2025, the court overruled plaintiffs’ objection to witness Suriya Bandara Jayawardena, M.D. (“Jayawardena”) providing testimony on medical necessity that he perceived in performing certain procedures. Upon its reconsideration the morning of November 21, 2025, the court sustained that part of plaintiffs’ objection seeking to exclude this and related testimony lodged in the present time, i.e. what is thought now, not at the point in time when treatment was provided and disputed claims made. And it struck from the jury’s consideration as that next trial day got underway, any corresponding portion of Jayawardena’s disallowed testimony from the day before. The court continued to allow, over plaintiffs’ objection, individual defendants and treating physicians to testify as to their own personal observations, knowledge of facts, and associated beliefs and opinions at the time when the doctors were engaged in the course of the complained about treatment and making claims therefor. The court memorializes herein its reasons for these rulings. BACKGROUND A. The False Claims Act This matter arises under the False Claims Act (“FCA”), 31 U.S.C. § 3729 et seq., and the

North Carolina False Claims Act, N.C. Gen. Stat. § 1-605 et seq.1 “The FCA (as relevant here) imposes liability on those who ‘knowingly present a false or fraudulent claim for payment or approval.’ Thus, two essential elements of an FCA violation are (1) the falsity of the claim and (2) the defendant's knowledge of the claim's falsity.” United States ex rel. Schutte v. SuperValu Inc., 598 U.S. 739, 747 (2023) (quoting 31 U.S.C. § 3729(a)(1)(A)). For purposes of the FCA, “Congress did not define what makes a claim ‘false’ or ‘fraudulent.’ But it is a settled principle of interpretation that, absent other indication, Congress intends to incorporate the well-settled meaning of the common-law terms it uses.” Universal Health Servs., Inc. v. United States ex rel. Escobar, 579 U.S. 176, 187 (2016) (quotation omitted).

“[R]epresentations that state the truth only so far as it goes, while omitting critical qualifying information [] can be actionable misrepresentations.” Id. at 188. Therefore, “the implied certification theory can be a basis for liability, at least where two conditions are satisfied: first, the claim does not merely request payment, but also makes specific representations about the goods or services provided; and second, the defendant's failure to disclose noncompliance with material statutory, regulatory, or contractual requirements makes those representations misleading half- truths.” Id. at 190. Under the FCA, a person acts “knowingly” if that person “has actual knowledge . . .acts in

1 Where the North Carolina False Claims Act “shall be interpreted and construed so as to be consistent with the federal False Claims Act,” N.C. Gen. Stat. § 1-616(c), the court focuses its analysis on the FCA. deliberate ignorance of the truth . . . or acts in reckless disregard of the truth.” 31 U.S.C. § 3729(b). “If a defendant knows that he lacks an honest belief in the statement's truth, that is often enough to establish scienter.” Schutte, 598 U.S. at 752 (quotation omitted). Medicare and Medicaid will reimburse healthcare providers only for items and services which are “reasonable and necessary for the diagnosis or treatment of illness or injury or to

improve the functioning of a malformed body member.” 42 U.S.C. § 1395y(a)(1)(A). According to the United States Centers for Medicare and Medicaid Services (“CMS”), a service is “reasonable and necessary” if the service is: o Safe and effective; o Not experimental or investigational . . . ; o Appropriate, including the duration and frequency that is considered appropriate for the . . . service, in terms of whether it is:  Furnished in accordance with accepted standards of medical practice for the diagnosis or treatment of the patient’s condition or to improve the function of a malformed body member;  Furnished in a setting appropriate to the patient’s medical needs and condition;  Ordered and furnished by qualified personnel;  One that meets, but does not exceed, the patient’s medical need; and  At least as beneficial as an existing and available medically appropriate alternative.

CMS Medicare Program Integrity Manual (CMS Pub. 100-08), § 13.5.4 (2019). Claims submitted to Medicare and Medicaid include a certification of compliance with this and other statutory and regulatory requirements. Plaintiffs alleged that defendants Matthew A. Daka, M.D. (“Daka”), Selvaratnam Sinna, M.D. (“Sinna”), and Manesh Thomas, M.D. (“Thomas”) (collectively, the “physician defendants”) and Jayawardena, a physician defendant who settled with plaintiffs just before trial, each performed unnecessary medical procedures during the years 2014 to 2017, and that claims for these procedures were presented to Medicare and Medicaid, falsely certifying that the procedures were medically necessary. Defendants contended that all the procedures were medically necessary. Thus, the question of falsity turns on whether the procedures performed by Jayawardena and the physician defendants were in fact medically necessary. And the question of scienter turns on whether defendants knew at the time the claims were submitted that the procedures were not

medically necessary. B. Disputed Testimony Plaintiffs called Jayawardena as a witness November 20, 2025. During cross-examination, plaintiffs raised a standing objection to any testimony from Jayawardena regarding medical necessity, arguing that the topic should be limited to discussion by experts. The objection was first noted when defense counsel asked Jayawardena, “Based upon the review of the ABI, the ultrasound, and the results of your angiogram test, do you believe that the procedure that you performed on Ms. Connell was medically necessary?” to which Jayawardena responded, “Yes, ma’am.”2 Jayawardena also was asked, “And do you believe that when you

submitted the claim for that procedure that it was medically necessary?” to which he responded, “Yes, ma’am.” Regarding a different patient, defense counsel asked, “And the fact that you didn’t find disease that could be intervened on during the performance of this procedure does that mean that this procedure was medically unnecessary?” to which Jayawardena responded, “No, ma’am.” Plaintiffs argued that Jayawardena was providing improper expert opinion testimony, and that if Jayawardena was permitted to continue doing so, plaintiffs’ other lay witnesses, also doctors, Santhosh Reddy Devarapally, M.D. (“Devarapally”) and Muhammad Marwali, M.D. (“Marwali”) should be permitted to provide similar testimony. The court overruled plaintiffs’

2 Quotations of testimony in this memorandum opinion are based upon the court’s rough notes of testimony at trial on November 20 and 21, 2025, where an official transcript has not yet been filed.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
United States of America and The State of North Carolina, ex rel. Santhosh Reddy Devarapally, M.D. v. Ferncreek Cardiology, P.A.; Matthew A. Daka, M.D.; Selvaratnam Sinna, M.D.; and Manesh Thomas, M.D., Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-of-america-and-the-state-of-north-carolina-ex-rel-santhosh-nced-2025.